Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature-Reference-Cited by-同舟云学术

Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature

Published:2020-06-22 Issue:2 Volume:190 Page:185-188
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Tepasse Phil‐Robin¹^ORCID,Hafezi Wali²,Lutz Mathias³,Kühn Joachim²,Wilms Christian¹,Wiewrodt Rainer³,Sackarnd Jan⁴,Keller Martin⁵,Schmidt Hartmut H.¹,Vollenberg Richard¹

Affiliation:

1. Department of Gastroenterology and Hepatology Section for Infectious Diseases University Hospital Muenster Muenster Germany

2. Institute of Virology University Hospital Muenster Muenster Germany

3. Department of Hematology and Oncology University Hospital Muenster Muenster Germany

4. Department of Cardiology and Angiology University Hospital Muenster Muenster Germany

5. Department of Anesthesiology Intensive Care Medicine and Pain Therapy University Hospital Muenster Muenster Germany

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16896

Reference14 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

2. Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.

3. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

4. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review

5. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case–Control Study from Astana, Kazakhstan;Medicina;2024-08-23

2. Exposure to obinutuzumab does not affect outcomes of SARS‐CoV‐2 infection in vaccinated patients with newly diagnosed advanced‐stage follicular lymphoma;British Journal of Haematology;2024-07-22

3. Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies;Viruses;2024-06-27

4. Harnessing immunity: Immunomodulatory therapies in COVID-19;World Journal of Virology;2024-06-25

5. Treatment of chronic COVID‐19 with convalescent/postvaccination plasma in patients with hematologic malignancies;International Journal of Cancer;2024-05-09